Cytiva - 17543802 - MabSelect SuRe, 200 mLItem must be purchased in units of 1

ITEM #: 3547828
Mab. Select ™ Su. Re ™ is a protein A affinity medium for capturing MAbs at process scale. Mab. Select ™ Su. Re ™ has an alkali-tolerant r. Protein A ligand that allows the use of rigorous and cost-effective CIP and sanitization protocols based on 0.1 to 0.5 M NaOH. Further, the ligand is protease stable leading to lower ligand leakage. Mab. Select ™ Su. Re ™ is a member of the Mab. Select ™ family of affinity chromatography media for the capture of monoclonal antibodies (MAbs) at process scale. Mab. Select ™ Su. Re ™ shares features and benefits of Mab. Select ™ such as a rigid, high-flow agarose matrix that ensures excellent pressure/flow properties, low non-specific binding that leads to low impurity levels in the eluate pool, and an oriented ligand coupling for optimal binding capacity. In addition, Mab. Select ™ Su. Re ™ features an alkali-tolerant r. Protein A ligand. This ligand provides greater stability than conventional protein A-based media in the alkaline conditions used in cleaning-in-place (CIP) and sanitization protocols. The enhanced alkali stability of Mab. Select ™ Su. Re ™ improves process economy and product quality; cleaning can be performed with cost-effective reagents such as sodium hydroxide eliminating the need for expensive and hazardous cleaning agents such as Gua-HCl. The novel ligand construct of Mab. Select ™ Su. Re ™ has been proven to have an increased stability towards proteases. Therefore, the level of leakage of the Mab. Select ™ Su. Re ™ ligand during elution is low. Mab. Select ™ Su. Re ™ has been demonstrated to give generic elution conditions for different monoclonal antibodies, which is an advantage when designing generic purification platform processes. This feature is also correlated to the construction of the Mab. Select ™ Su. Re ™ ligand. Mab. Select ™ Su. Re ™ is available in a range of different bulk pack sizes and convenient pre-packed formats for easy scale-up and process development. As member of the Bio. Process media range, Mab. Select ™ Su. Re ™ meets industrial demands with security of supply and comprehensive technical and regulatory support.
• Novel, alkali-tolerant r. Protein A ligand withstands rigorous CIP and sanitization procedures with 0.1 to 0.5 M NaOH. • Reduces the risk of product contamination and carryover • Improves product quality and reduces overall costs • Novel ligand design gives enhanced protease resistance resulting in lower ligand leakage • Generic elution profile for different monoclonal antibodies enables platform approach to purification • Used in the commercial manufacture of monoclonal antibodies • High-flow agarose matrix allows the processing of large feed volumes
.
Free Mab. Select Su. Re Ligand "Mab. Select Su. Re Ligand Restricted License" and "Cys-r. Protein A Ligand Restricted License" are protected by the following patents and equivalent patents and patent applications in other countries: US 6, 399, 750 and EP 1123389. A free, non-transferable limited license to use this product for internal analytical purposes only accompanies the purchase of the product from a Cytiva company and its licensed distributors. Any other use will require a separate license from a Cytiva company.
Mab. Select is a trademark of Cytiva
Su. Re is a trademark of Cytiva